Back to User profile » Prof. Dr. Elke MGJ De Jong
Papers published by Prof. Dr. Elke MGJ De Jong:
Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE Study
Mrowietz U, Sommer R, Reguiai Z, Gerdes S, Daudén E, Weger W, Maul JT, Naldi L, Ghislain PD, Laws PM, De Jong EMGJ, Mburu S, Koscielny V, Massana E, Sapena V, Domenech A, Kasujee I, Augustin M
Psoriasis: Targets and Therapy 2026, 16:590189
Published Date: 12 May 2026
Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV Positive Study
Mrowietz U, Sommer R, Gerdes S, Reguiai Z, Weger W, Daudén E, Maul JT, Ghislain PD, Laws PM, Naldi L, De Jong E, Mburu S, Koscielny V, Massana E, Domenech A, Gaarn du Jardin K, Kasujee I, Augustin M
Psoriasis: Targets and Therapy 2025, 15:243-259
Published Date: 28 June 2025
The Effect of Lifestyle Changes on Disease Severity and Quality of Life in Patients with Plaque Psoriasis: A Narrative Review
van Acht MR, van den Reek JMPA, de Jong EMGJ, Seyger MMB
Psoriasis: Targets and Therapy 2022, 12:35-51
Published Date: 9 April 2022
The Skin May Clear But the Arthritis Won’t Disappear: Focusing on Concomitant and New-Onset Psoriatic Arthritis in a Daily Practice Cohort of Psoriasis Patients on Biologic Therapy
van Muijen ME, van Hal TW, Groenewoud HMM, van den Reek JMPA, de Jong EMGJ
Psoriasis: Targets and Therapy 2020, 10:29-37
Published Date: 5 October 2020